Lanean...
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
Newly diagnosed high grade serous epithelial ovarian cancer (EOC) patients are treated with radical surgery followed by adjuvant platinum and taxane combination chemotherapy. In EOC patients where upfront surgery is contraindicated for medical reasons (e.g., comorbidities or poor performance status)...
Gorde:
| Argitaratua izan da: | Ann Transl Med |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812234/ https://ncbi.nlm.nih.gov/pubmed/33490222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1683 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|